Skip to main content

Table 1 Clinical characteristics at baseline and secondary clinical outcomes of the two groups

From: Short-term effects of high-dose oral vitamin D3 in critically ill vitamin D deficient patients: a randomized, double-blind, placebo-controlled pilot study

  Placebo
(n= 13)
Vitamin D
(n= 12)
P value
Baseline characteristics    
Male - n (%) 10 (77) 9 (75) 0.91
Age (years) 64.1 ± 16.4 61.1 ± 16.7 0.65
Body mass Index (kg/m2) 29.3 ± 8.5 28.7 ± 9.7 0.87
SAPS II (ICU admission) 38.3 ± 22.3 33.2 ± 12.2 0.47
TISS (study start) 38.0 ± 7.2 30.2 ± 7.1 0.08
Renal replacement therapy - n (%) 3 (23) 1 (8) 0.31
Diagnostic category infectious (4) infectious (6)  
  cardiovascular (4) cardiovascular (3)  
  neurologic (4) neurologic (1) -
  gastrointestinal (1) gastrointestinal (0)  
  other (0) other (2)  
Mechanical ventilation - n (%) 11 (85) 10 (83) 0.93
Vasopressor therapy - n (%) 12 (92) 8 (67) 0.10
Outcome variables    
Mechanical ventilation - duration (hours) 163 (91-541) 229 (82-366) 0.88
Vasopressor therapy - duration (hours) 146 (48-351) 65 (42-299) 0.56
Hospital stay, days (from study start) 15 (8-38) 16 (8-32) 0.97
ICU stay, days (from study start) 6 (3-23) 10 (5-21) 0.54
Hospital mortality - n (%) 6 (46) 6 (50) 0.84
  1. Continuous data are presented as means (standard deviation) or median (interquartile range), categorical data are shown in total numbers (percentages).
  2. SAPS, simplified acute physiology score; TISS 28, Therapeutic Intervention Scoring System.